- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar subsidiary purchases MSO
Fonar's physician practice management subsidiary, U.S. Health Management, has purchased a managed service organization (MSO) managing four high-volume primary-care practices in New York City. The practices are expected to add about $2 million to HMC's
Fonar's physician practice management subsidiary, U.S. Health Management, has purchased a managed service organization (MSO) managing four high-volume primary-care practices in New York City. The practices are expected to add about $2 million to HMC's operating profits over the next twelve months, according to Fonar of Melville, NY.
Accounting for over 52,000 patient visits per year, the practices have experienced an annual growth rate of 30% over the past five years and have contracts with several third-party payors and major managed-care organizations, according to Fonar. Fonar president and chairman Dr. Raymond Damadian said he is pleased with the growth of the HMC subsidiary and is encouraged by the potential the expansion offers for future Fonar MRI sales.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
